Welcome to LookChem.com Sign In|Join Free
  • or
5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione, also known as tetrahydroxanthen-1,3-dione, is a yellow crystalline solid with the molecular formula C13H10O3. It is a chemical compound that serves as an intermediate in the synthesis of various pharmaceuticals and organic compounds. Known for its potential biological activities, including anti-inflammatory, anticancer, and antimicrobial properties, 5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione has garnered interest in drug development and medical research for the treatment of a range of diseases and conditions. Despite its promising applications, the exact mechanisms of action and potential side effects of 5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione are still under investigation, necessitating further research to fully explore its therapeutic potential.

3711-74-8

Post Buying Request

3711-74-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3711-74-8 Usage

Uses

Used in Pharmaceutical Industry:
5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione is used as a chemical intermediate for the synthesis of various pharmaceuticals and organic compounds. Its role in the creation of new drugs is crucial, as it can be a precursor to molecules with therapeutic applications.
Used in Drug Development:
As a compound with potential biological activities, 5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione is used in drug development for its anti-inflammatory, anticancer, and antimicrobial properties. Researchers are exploring its potential to treat various diseases and conditions, making it a valuable asset in the search for new therapeutic agents.
Used in Medical Research:
5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione is utilized in medical research to study its mechanisms of action and potential side effects. Understanding these aspects is essential for determining the safety and efficacy of 5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione in clinical applications.
While the provided materials do not specify different applications in various industries, the primary uses of 5,6,7,8-Tetrahydro-1H-2-benzopyran-1,3(4H)-dione are centered around its role in the pharmaceutical and medical research fields. Its potential applications in these areas are significant, given its biological activities and the ongoing investigations into its therapeutic potential.

Check Digit Verification of cas no

The CAS Registry Mumber 3711-74-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,7,1 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 3711-74:
(6*3)+(5*7)+(4*1)+(3*1)+(2*7)+(1*4)=78
78 % 10 = 8
So 3711-74-8 is a valid CAS Registry Number.

3711-74-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,6,7,8-Tetrahydro-1H-isochromene-1,3(4H)-dione

1.2 Other means of identification

Product number -
Other names 5,6,7,8-tetrahydro-4H-isochromene-1,3-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3711-74-8 SDS

3711-74-8Relevant academic research and scientific papers

SUBSTITUTED TETRACYCLIC 1H-INDENO (1,2-B) PYRIDINE-2 (5H)-ONE ANALOGS THEREOF AND USES THEREOF

-

Page/Page column 75; 79-80, (2010/08/04)

Provided herein are tetracyclic 1H-indeno[1,2-b]pyridine-2(5H)-one analogs and derivatives, compositions comprising an effective amount of a tetracyclic 1H- indeno[1,2-b]pyridine-2(5H)-one analog and/or derivative and methods for treating or preventing an

Evaluation of retinoid lactones as topical therapeutic agents in dermatology

Lewin,Black,Bos,Goehring,Nair,Whiting,Bouquin,Tetrault,Carroll

, p. 983 - 992 (2007/10/03)

Purpose. Optimization of the therapeutic ratio of analogs of the topically active 11-cis,13-cis-12-hydroxymethylretinoic acid, δ-lactone (I) relative to antihyperproliferation and antihyperkeratinization vs. toxicity. Methods. Nine analogs of 1, in which variations were made in the lipophilic cyclohexenyl moiety or in the lactone ring, were evaluated for topical activity against hyperkeratinization, inhibition of TPA-induced DNA synthesis and for skin irritation. Results. Although more potent lactones than the parent lactone 1 were identified, none possessed the favorable therapeutic ratio associated with 1. Conclusions. The δ-lactone 1 possesses unique molecular features responsible for its desirable therapeutic ratio as an anti-hyperproliferative and antihyperkeratotic agent. In view of its very low systemic retinoid toxicity and the absence of any systemic toxicity, this lactone may be a good candidate for use in the topical treatment of acne.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3711-74-8